APA

Nappi A., Perrella A., Rinaldi L., Izzi A., Punzi R., Adinolfi L. E., Sbeglia C., Bellopede P., Maddaloni A., Papa N. & Spatarella M. (2019). Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?. : European journal of hospital pharmacy : science and practice.

Chicago

Nappi Antonella, Perrella Alessandro, Rinaldi Luca, Izzi Antonio, Punzi Rodolfo, Adinolfi Luigi Elio, Sbeglia Costanza, Bellopede Pasquale, Maddaloni Adelaide, Papa Nunzia and Spatarella Micaela. 2019. Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?. : European journal of hospital pharmacy : science and practice.

Harvard

Nappi A., Perrella A., Rinaldi L., Izzi A., Punzi R., Adinolfi L. E., Sbeglia C., Bellopede P., Maddaloni A., Papa N. and Spatarella M. (2019). Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?. : European journal of hospital pharmacy : science and practice.

MLA

Nappi Antonella, Perrella Alessandro, Rinaldi Luca, Izzi Antonio, Punzi Rodolfo, Adinolfi Luigi Elio, Sbeglia Costanza, Bellopede Pasquale, Maddaloni Adelaide, Papa Nunzia and Spatarella Micaela. Late HCC onset after DAAs therapy in patients with SVR: a type D ADR that requires a longer follow-up?. : European journal of hospital pharmacy : science and practice. 2019.